Taking Bold Bets: NIH and the Future of Biomedical Science

Dr. Jay Bhattacharya is one of the country’s top medical experts and a 24-year professor of medicine at Stanford. After being censored and deplatformed during COVID for his role in opposing harsh lockdowns, he was appointed Director of the National Institutes of Health by President Trump in 2025. a16z General Partners Erik Torenberg, Vineeta Agarwala, and Jorge Conde join Dr. Bhattacharya to discuss the administration’s role in tackling the autism crisis, how to restore public trust in health authorities, how to make the NIH more dynamic and efficient, and how to streamline publishing and restore academic freedom. Timecodes: 00:00 Introduction 00:59 Autism Research Initiatives Announced 02:01 New Findings: Leucovorin and Tylenol in Pregnancy 04:40 Addressing Preterm Birth & Broader Health Concerns 06:10 The Replication Crisis in Science 09:26 NIH Funding, Grant Review, and the Silicon Valley Spirit 12:47 Grant and Review Process 14:26 Portfolio Management & Allocation at NIH 26:23 The Challenge of Supporting Early Career Investigators 31:23 Allocating Grants and Training Under the New Administration 35:46 Academic Freedom and Scientific Publishing 38:34 Rebuilding Public Trust in Science & Public Health 41:57 Communicating Uncertainty & Scientific Honesty 48:58 NIH Priorities: Nutrition, Chronic Disease, and AI 54:15 Advice for the Next Generation of Scientists 56:37 The Role and Limits of AI in Science Resources: Find Dr. Bhattacharya on X: https://x.com/DrJBhattacharya and https://x.com/NIHDirector_Jay Find Erik on X: https://x.com/eriktorenberg Find Jorge on X: https://x.com/JorgeCondeBio Find Vineeta on X: https://x.com/vintweeta Learn more about the NIH: https://www.nih.gov/ Stay Updated: If you enjoyed this episode, be sure to like, subscribe, and share with your friends! Find a16z on X: https://x.com/a16z Find a16z on LinkedIn: https://www.linkedin.com/company/a16z Listen to the a16z Podcast on Spotify: https://open.spotify.com/show/5